# The Role of Interventional Pulmonology, Microbiota and Immune Response in the Patient With Lung Cancer

> **NCT05164445** · NA · COMPLETED · sponsor: **Lithuanian University of Health Sciences** · enrollment: 200 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Transbronchial forceps biopsy
- **DIAGNOSTIC_TEST:** Transbronchial forceps biopsy+Transbronchial cryobiopsy

## Key facts

- **NCT ID:** NCT05164445
- **Lead sponsor:** Lithuanian University of Health Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-01
- **Primary completion:** 2023-02-01
- **Final completion:** 2023-08-31
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2023-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05164445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05164445, "The Role of Interventional Pulmonology, Microbiota and Immune Response in the Patient With Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05164445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*